Verrica Pharmaceuticals (VRCA) Leases (2021 - 2025)
Verrica Pharmaceuticals (VRCA) has 5 years of Leases data on record, last reported at $1.1 million in Q4 2025.
- For Q4 2025, Leases rose 33.13% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $1.1 million, up 33.13%, while the annual FY2025 figure was $1.1 million, 33.13% up from the prior year.
- Leases reached $1.1 million in Q4 2025 per VRCA's latest filing, up from $1.0 million in the prior quarter.
- Across five years, Leases topped out at $2.6 million in Q3 2024 and bottomed at $836000.0 in Q4 2024.
- Average Leases over 5 years is $1.4 million, with a median of $1.3 million recorded in 2023.
- Peak YoY movement for Leases: surged 97.09% in 2024, then tumbled 60.21% in 2025.
- A 5-year view of Leases shows it stood at $1.6 million in 2021, then dropped by 5.91% to $1.5 million in 2022, then dropped by 23.46% to $1.2 million in 2023, then decreased by 27.81% to $836000.0 in 2024, then surged by 33.13% to $1.1 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $1.1 million in Q4 2025, $1.0 million in Q3 2025, and $945000.0 in Q2 2025.